Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · IEX Real-Time Price · USD
+0.030 (3.32%)
At close: Nov 27, 2023, 4:00 PM
-0.020 (-2.14%)
After-hours: Nov 27, 2023, 5:49 PM EST

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $7.20M in the twelve months ending September 30, 2023, with 49.15% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $2.53M with 19.70% year-over-year growth. In the year 2022, Bolt Biotherapeutics had annual revenue of $5.73M with 354.68% growth.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
35.30M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20225.73M4.47M
Dec 31, 20211.26M1.03M
Dec 31, 2020231.00K16.00K
Dec 31, 2019215.00K--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Retractable Technologies 41.99M
Co-Diagnostics 4.66M
IceCure Medical 2.91M
BeyondSpring 1.35M
OncoCyte -2.36M
Revenue Rankings